Literature DB >> 1448170

Cloning and expression of a rat brain L-glutamate transporter.

G Pines1, N C Danbolt, M Bjørås, Y Zhang, A Bendahan, L Eide, H Koepsell, J Storm-Mathisen, E Seeberg, B I Kanner.   

Abstract

Synaptic transmission of most vertebrate synapses is thought to be terminated by rapid transport of the neurotransmitter into presynaptic nerve terminals or neuroglia. L-Glutamate is the major excitatory transmitter in brain and its transport represents the mechanism by which it is removed from the synaptic cleft and kept below toxic levels. Here we use an antibody against a glial L-glutamate transporter from rat brain to isolate a complementary DNA clone encoding this transporter. Expression of this cDNA in transfected HeLa cells indicates that L-glutamate accumulation requires external sodium and internal potassium and transport shows the expected stereospecificity. The cDNA sequence predicts a protein of 573 amino acids with 8-9 putative transmembrane alpha-helices. Database searches indicate that this protein is not homologous to any identified protein of mammalian origin, including the recently described superfamily of neurotransmitter transporters. This protein therefore seems to be a member of a new family of transport molecules.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1448170     DOI: 10.1038/360464a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  232 in total

1.  Neutral amino acid transporter ASCT2 displays substrate-induced Na+ exchange and a substrate-gated anion conductance.

Authors:  A Bröer; C Wagner; F Lang; S Bröer
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

2.  Freshly isolated hippocampal CA1 astrocytes comprise two populations differing in glutamate transporter and AMPA receptor expression.

Authors:  M Zhou; H K Kimelberg
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

Review 3.  Structural features of the glutamate transporter family.

Authors:  D J Slotboom; W N Konings; J S Lolkema
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

Review 4.  Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission.

Authors:  Arne Schousboe
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

5.  A postsynaptic excitatory amino acid transporter with chloride conductance functionally regulated by neuronal activity in cerebellar Purkinje cells.

Authors:  Y Kataoka; H Morii; Y Watanabe; H Ohmori
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

6.  Treadmill pre-training suppresses the release of glutamate resulting from cerebral ischemia in rats.

Authors:  Jie Jia; Yong-Shan Hu; Yi Wu; Hui-Xian Yu; Gang Liu; Da-Nian Zhu; Chun-Mei Xia; Zhi-Juan Cao; Xi Zhang; Qing-Chuan Guo
Journal:  Exp Brain Res       Date:  2010-06-10       Impact factor: 1.972

Review 7.  Roles of reactive oxygen and nitrogen species in pain.

Authors:  Daniela Salvemini; Joshua W Little; Timothy Doyle; William L Neumann
Journal:  Free Radic Biol Med       Date:  2011-01-28       Impact factor: 7.376

8.  Asymmetry of glia near central synapses favors presynaptically directed glutamate escape.

Authors:  Knut Petter Lehre; Dmitri A Rusakov
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

9.  Proteome analysis and conditional deletion of the EAAT2 glutamate transporter provide evidence against a role of EAAT2 in pancreatic insulin secretion in mice.

Authors:  Yun Zhou; Leonie F Waanders; Silvia Holmseth; Caiying Guo; Urs V Berger; Yuchuan Li; Anne-Catherine Lehre; Knut P Lehre; Niels C Danbolt
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

10.  WAY-855 (3-amino-tricyclo[2.2.1.02.6]heptane-1,3-dicarboxylic acid): a novel, EAAT2-preferring, nonsubstrate inhibitor of high-affinity glutamate uptake.

Authors:  John Dunlop; Scott Eliasof; Gary Stack; H Beal McIlvain; Alexander Greenfield; Dianne Kowal; Robert Petroski; Tikva Carrick
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.